Jakob Wilhelm Stuhlfelder

Mr. Jakob Wilhelm Stuhlfelder

Universitätsklinikum Hamburg Eppendorf

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2022 in Cancers
Verified
Journal Article
Open access
PDF file
BSBjörn-Ole Stüben
Björn-Ole Stüben
Jakob Wilhelm StuhlfelderJakob Wilhelm Stuhlfelder
Jakob Wilhelm Stuhlfelder
MKMarius Kemper
Marius Kemper
MTMichael Tachezy
Michael Tachezy
TGTarik Ghadban
Tarik Ghadban
MRMatthias Reeh
Matthias Reeh
Esophageal cancer is the eighth most common cancer worldwide, with poor prognosis and high mortality. The combination of surgery and systemic therapy provide the best chances for long-term survival. The purpose of this study was to analyze the impact of the FLOT protocol on the overall survival of patients following surgery for esophageal adenocarcinoma, with a focus on the patients who did not benefit in terms of pathological remission from the neoadjuvant therapy. A retrospective analysis of all the patients who underwent esophagectomies from 2012 to 2017 for locally advanced adenocarcinomas of the esophagus at a tertiary medical center was performed. The results show that the completion of systemic therapy, regardless of the tumor regression grading, had a significant positive impact on the overall survival. The patients with complete regression and complete systemic therapy showed the best outcomes. Anastomotic insufficiency did not negatively impact the long-term survival, while complications of the systemic therapy led to significantly reduced overall survival. We conclude that adjuvant systemic therapy should, when possible, always be completed, regardless of the tumor regression, following an esophagectomy.